71 results
Page 2 of 4
424B5
sswaoz ld2kt9
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K/A
EX-99.1
y7m2fap
23 Nov 20
Consolidated Financial Statements
12:00am
424B7
u277vpjo v358
5 Nov 20
Prospectus with selling stockholder info
5:27pm
8-K
EX-10.3
ln0 5xted1zue
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
kv0uavbk z6
28 Aug 20
Prospectus supplement
4:31pm
425
20ymcp6
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
6dt2yvxrq
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-1.1
adxwj d9k18evpi
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
lsjd 1edq
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
m685n37s
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K/A
EX-99.1
r6q6f9f7
28 Aug 19
Statement of Operations
4:05pm
8-K/A
EX-99.2
27r509srwf1aus6y4q
28 Aug 19
Statement of Operations
4:05pm